SELLAS Life Sciences Group Inc (SLS)

1.01 +0.08 (+8.66%) USD  |  NASDAQ  |  Dec 26, 16:00
1.03 +0.02 (+1.98%) After-Hours: 20:00
More

SELLAS Life Sciences Group Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Microbot Medical Inc Upgrade
Alaunos Therapeutics Inc Upgrade
Galectin Therapeutics Inc Upgrade
Oragenics Inc Upgrade
Anavex Life Sciences Corp Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade